The Chemours Company (NYSE:CC) Receives $22.56 Consensus PT from Analysts

The Chemours Company (NYSE:CC - Get Free Report) has been given an average recommendation of "Moderate Buy" by the nine ratings firms that are covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $22.56.

A number of equities analysts have weighed in on the company. Morgan Stanley decreased their price target on Chemours from $25.00 to $22.00 and set an "equal weight" rating for the company in a report on Monday, January 13th. The Goldman Sachs Group lowered their price target on shares of Chemours from $24.00 to $21.00 and set a "neutral" rating for the company in a report on Tuesday, January 7th. Barclays cut their price target on Chemours from $19.00 to $16.00 and set an "equal weight" rating on the stock in a research note on Tuesday, April 1st. Mizuho raised shares of Chemours from a "neutral" rating to an "outperform" rating and set a $19.00 price objective for the company in a report on Thursday, March 27th. Finally, Truist Financial assumed coverage on shares of Chemours in a research note on Tuesday, January 28th. They issued a "buy" rating and a $27.00 target price on the stock.

Chemours Trading Up 4.3 %

NYSE:CC traded up $0.47 during trading hours on Tuesday, reaching $11.28. 2,251,986 shares of the company were exchanged, compared to its average volume of 1,817,331. Chemours has a 52-week low of $9.33 and a 52-week high of $29.21. The stock has a 50 day simple moving average of $14.54 and a 200 day simple moving average of $17.62. The firm has a market cap of $1.68 billion, a price-to-earnings ratio of 19.78 and a beta of 1.84. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92.

Remove Ads

Chemours (NYSE:CC - Get Free Report) last released its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The company had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.37 billion. As a group, analysts predict that Chemours will post 2.03 EPS for the current year.

Chemours Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 8.87%. The ex-dividend date was Friday, February 28th. Chemours's dividend payout ratio (DPR) is presently 175.44%.

Hedge Funds Weigh In On Chemours

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Matrix Trust Co grew its position in shares of Chemours by 64.9% during the 1st quarter. Matrix Trust Co now owns 16,408 shares of the specialty chemicals company's stock worth $222,000 after buying an additional 6,456 shares during the period. RFG Advisory LLC acquired a new position in shares of Chemours during the 1st quarter worth approximately $968,000. GAMMA Investing LLC increased its holdings in shares of Chemours by 1,115.2% in the first quarter. GAMMA Investing LLC now owns 18,617 shares of the specialty chemicals company's stock valued at $252,000 after purchasing an additional 17,085 shares during the last quarter. Polar Asset Management Partners Inc. bought a new position in shares of Chemours in the fourth quarter valued at about $2,392,000. Finally, iSAM Funds UK Ltd acquired a new stake in shares of Chemours during the 4th quarter worth about $332,000. 76.26% of the stock is currently owned by institutional investors and hedge funds.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.